Home SPRO
2.00
  Price3.84%   -0.07
 
loading
Oct-04-22 02:29AM EXCLUSIVE: Top 10 Stocks Searched On Benzinga Pro In September: Where Do Tesla, Apple, Bed Bath & Beyond Rank?Benzinga
Oct-03-22 08:05AM Spero Therapeutics to Host Virtual R&D Event on Non-Tuberculous Mycobacterial Pulmonary Disease and the SPR720 ProgramGlobeNewswire Inc.
Sep-30-22 06:32AM Cheap Stocks To Buy Now? Hot Penny Stocks To Watch In OctoberPennyStocks
Sep-26-22 02:30AM Hot Penny Stocks To Watch As The Stock Market Crash ContinuesPennyStocks
08:28AM This Analyst Slashes PT On Lyft By 68%, Plus Telsey Advisory Group Predicts $125 For NikeBenzinga
Sep-23-22 11:02AM Spero (SPRO) Skyrockets 168% on Licensing Deal With GSKZacks Investment Research
09:59AM Spero Therapeutics To Rally Around 240%? Plus This Analyst Slashes PT On SalesforceBenzinga
Sep-23-22 06:00AM Reddit Penny Stocks to Watch as September Ends PennyStocks
03:42AM Why Avenue Therapeutics Shares Surged Around 106%; Here Are 87 Biggest Movers From YesterdayBenzinga
Sep-22-22 03:10AM Dow Turns Higher; Crude Oil Rises 0.7%Benzinga
12:26PM Why MediWound Is Trading Lower By Around 18%, Here Are 48 Stocks Moving In Thursday's Mid-Day SessionBenzinga
Sep-22-22 12:26PM Nasdaq Drops Over 100 Points; Spero Therapeutics Shares Spike HigherBenzinga
11:47AM Penny Stocks To Buy Now: 3 To Watch Under $3PennyStocks
Sep-22-22 08:22AM Top Financial Media Stories Thursday, September 22: Facebook Sued For Bypassing Apple Privacy Rules, Walmart Slows Hiring Plans Ahead Of Holiday Season, China Blames US For Northwestern Polytechnical University Hack And More..Benzinga
07:23AM US Stocks Could Remain Jittery Thursday Over Fed Rate Hike As S&P 500, Nasdaq Futures See Volatility — McDonald's In FocusBenzinga
Sep-22-22 06:34AM Why Spero Therapeutics Is Trading Higher By Over 105%; Here Are 21 Stocks Moving PremarketBenzinga
02:00AM GSK and Spero Therapeutics Announce Exclusive License Agreement for Late-Stage Antibiotic Asset, Tebipenem HBrGlobeNewswire Inc.
Sep-19-22 06:53AM Why bluebird bio Is Trading Higher By Around 19%; Here Are 31 Stocks Moving PremarketBenzinga
Sep-15-22 04:05AM Spero Therapeutics Announces Appointment of Kamal Hamed, MD, MPH, MBA, as Chief Medical OfficerGlobeNewswire Inc.
Sep-08-22 06:00AM Looking for Popular Penny Stocks to Buy? 3 to Watch NowPennyStocks
05:26AM Why IMARA Jumped Around 75%; Here Are 54 Biggest Movers From YesterdayBenzinga
Sep-07-22 12:37PM Biotech Stock Roundup: GILD's Updates, FMTX Up on NVO Deal, SPRO Surges & MoreZacks Investment Research
12:22PM Why Korn Ferry Is Trading Lower By Over 8%, Here Are 40 Stocks Moving In Wednesday's Mid-Day SessionBenzinga
Sep-07-22 10:36AM Spero (SPRO) Up Following Positive FDA Update for UTI DrugZacks Investment Research
08:05AM Spero Therapeutics to Present at Upcoming Investor ConferenceGlobeNewswire Inc.
Sep-07-22 06:48AM Why Coupa Software Is Trading Higher By Over 12%; Here Are 24 Stocks Moving PremarketBenzinga
06:00AM Are These Penny Stocks on Your September Buy List?PennyStocks
Sep-07-22 05:16AM Why Allena Pharmaceuticals Tumbled Over 30%; Here Are 85 Biggest Movers From YesterdayBenzinga
Sep-06-22 01:36AM Why HyreCar Is Trading Higher By 60%, Here Are 63 Stocks Moving In Tuesday's Mid-Day SessionBenzinga
08:05AM Spero Therapeutics Provides Tebipenem HBr Program Update Following Type A Meeting with the U.S. Food and Drug AdministrationGlobeNewswire Inc.
Aug-25-22 09:55AM Spero Therapeutics, Inc. (SPRO) May Find a Bottom Soon, Here's Why You Should Buy the Stock NowZacks Investment Research
Aug-18-22 04:59AM This Healthcare Stock Dipped Over 30%; Here Are 83 Biggest Movers From YesterdayBenzinga
Aug-10-22 05:25AM Spero Therapeutics, Inc. (SPRO) Reports Q2 Loss, Misses Revenue EstimatesZacks Investment Research
04:05AM Spero Therapeutics Announces Second Quarter 2022 Operating Results and Provides Business UpdateGlobeNewswire Inc.
Aug-09-22 08:05AM Spero Therapeutics to Provide Business Update and Report Second Quarter 2022 Financial Results on Wednesday, August 10, 2022GlobeNewswire Inc.
May-20-22 10:02AM Benzinga's Top Ratings Upgrades, Downgrades For May 20, 2022Benzinga
May-17-22 09:15AM Where Spero Therapeutics Stands With AnalystsBenzinga
May-16-22 05:35AM Spero Therapeutics, Inc. (SPRO) Reports Q1 Loss, Lags Revenue EstimatesZacks Investment Research
May-12-22 08:35AM Ikena Oncology, Inc. (IKNA) Reports Q1 Loss, Tops Revenue EstimatesZacks Investment Research
May-11-22 08:05AM Spero Therapeutics to Present at Upcoming Investor ConferencesGlobeNewswire Inc.
May-09-22 08:05AM Spero Therapeutics to Provide Business Update and Report First Quarter 2022 Financial Results on Monday, May 16, 2022GlobeNewswire Inc.
May-04-22 10:17AM Benzinga's Top Ratings Upgrades, Downgrades For May 4, 2022Benzinga
09:15AM Clovis Oncology (CLVS) Reports Q1 Loss, Lags Revenue EstimatesZacks Investment Research
Apr-28-22 03:02AM Earnings Preview: Spero Therapeutics, Inc. (SPRO) Q1 Earnings Expected to DeclineZacks Investment Research
Apr-21-22 08:05AM Spero Therapeutics to Present Data at the 32nd European Congress of Clinical Microbiology and Infectious DiseasesGlobeNewswire Inc.
Spero Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on identifying, developing, and commercializing novel treatments for multi-drug resistant (MDR) bacterial infections in the United States. Its product candidate includes SPR994, an oral carbapenem-class antibiotic to treat MDR gram-negative infections for adults; and SPR741, which is in Phase Ib clinical trial to treat MDR gram-negative infections in the hospital setting. The company also develops SPR206, an agent that is in preclinical development stage to disrupt the outer membrane of gram-negative bacteria; SPR720, an oral antibiotic, which is in preclinical development stage for the treatment of pulmonary non-tuberculous mycobacterial infections. Spero Therapeutics, Inc. was founded in 2013 and is headquartered in Cambridge, Massachusetts.
Cap:    |  Volume (24h):